Cell-based Therapy for Hypertension: Challenges and Perspectives

被引:1
作者
Gasparotto Junior, Arquimedes [1 ]
dos Reis Livero, Francislaine Aparecida [2 ]
机构
[1] Fed Univ Grande Dourados, Fac Hlth Sci, Lab Electrophysiol & Cardiovasc Pharmacol, Rodovia Dourados Itahum,Km 12,POB 533, BR-79804970 Dourados, MS, Brazil
[2] Univ Paranaense, Lab Preclin Res Nat Prod, Umuarama, PR, Brazil
关键词
Chronic non-communicable disease; hypertension; stem-cell therapy; unconventional treatment; herbal medicines; antibodies; PULMONARY ARTERIAL-HYPERTENSION; PLURIPOTENT STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; ACUTE MYOCARDIAL-INFARCTION; MARROW MONONUCLEAR-CELLS; ISCHEMIC-HEART-DISEASE; EXTRACELLULAR VESICLES; BLOOD-PRESSURE; IN-VITRO; CARDIAC DIFFERENTIATION;
D O I
10.2174/1381612824666180903142858
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Hypertension is a non-transmissible chronic disease with a high prevalence, morbidity, and mortality. Different strategies for the treatment of hypertension are employed worldwide, but the control of hypertension remains a major challenge for global health. Many unsuccessful unconventional therapies have been proposed in recent years, including herbal medicines and the development of small molecules or antibodies that seek to disrupt the disease's pathogenesis. Cell-based therapies may be used as replacement or complementary treatment strategies. The results of recent preclinical studies of cell-based therapies are promising. However, human clinical trials are scarce, the data are insipid, and many issues have been raised about the safety and efficacy of cell-based therapies. The present review summarizes research on cell-based therapy for hypertension. We also briefly summarize relevant clinical trials and discuss future perspectives and possible clinical applications.
引用
收藏
页码:3084 / 3089
页数:6
相关论文
共 96 条
  • [21] Regenerative Cell and Tissue-based Therapies for Pulmonary Arterial Hypertension
    Foster, William S.
    Suen, Colin M.
    Stewart, Duncan J.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (11) : 1350 - 1360
  • [22] Contribution of Bone Marrow-Derived Hematopoietic Stem/Progenitor Cells to the Generation of Donor-Marker+ Cardiomyocytes In Vivo
    Fukata, Mitsuhiro
    Ishikawa, Fumihiko
    Najima, Yuho
    Yamauchi, Takuji
    Saito, Yoriko
    Takenaka, Katsuto
    Miyawaki, Kohta
    Shimazu, Hideki
    Shimoda, Kazuya
    Kanemaru, Takaaki
    Nakamura, Kei-ichiro
    Odashiro, Keita
    Nagafuji, Koji
    Harada, Mine
    Akashi, Koichi
    [J]. PLOS ONE, 2013, 8 (05):
  • [23] REBUILDING THE DAMAGED HEART: MESENCHYMAL STEM CELLS, CELL-BASED THERAPY, AND ENGINEERED HEART TISSUE
    Golpanian, Samuel
    Wolf, Ariel
    Hatzistergos, Konstantinos E.
    Hare, Joshua M.
    [J]. PHYSIOLOGICAL REVIEWS, 2016, 96 (03) : 1127 - 1168
  • [24] The 2017 American College of Cardiology/American Heart Association vs Hypertension Canada High Blood Pressure Guidelines and Potential Implications
    Goupil, Remi
    Lamarre-Cliche, Maxime
    Vallee, Michel
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2018, 34 (05) : 665 - 669
  • [25] Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension The PHACeT Trial
    Granton, John
    Langleben, David
    Kutryk, Michael B.
    Camack, Nancy
    Galipeau, Jacques
    Courtman, David W.
    Stewart, Duncan J.
    [J]. CIRCULATION RESEARCH, 2015, 117 (07) : 645 - 654
  • [26] Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study
    Hennein, Rachel
    Hwang, Shih-Jen
    Au, Rhoda
    Levy, Daniel
    Muntner, Paul
    Fox, Caroline S.
    Ma, Jiantao
    [J]. INTERNAL MEDICINE JOURNAL, 2018, 48 (04) : 414 - 421
  • [27] Risk factors in the development of stem cell therapy
    Herberts, Carla A.
    Kwa, Marcel S. G.
    Hermsen, Harm P. H.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [28] Exercise and other nonpharmacological strategies to reduce blood pressure in older adults: a systematic review and meta-analysis
    Herrod, Philip J. J.
    Doleman, Brett
    Blackwell, James E. M.
    O'Boyle, Francesca
    Williams, John P.
    Lund, Jonathan N.
    Phillips, Bethan E.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2018, 12 (04) : 248 - 267
  • [29] A chemically defined culture of VEGFR2+ cells derived from embryonic stem cells reveals the role of VEGFR1 in tuning the threshold for VEGF in developing endothelial cells
    Hirashima, M
    Ogawa, M
    Nishikawa, S
    Matsumura, K
    Kawasaki, K
    Shibuya, M
    Nishikawa, SI
    [J]. BLOOD, 2003, 101 (06) : 2261 - 2267
  • [30] Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis
    Hirashima, M
    Kataoka, H
    Nishikawa, S
    Matsuyoshi, N
    Nishikawa, SI
    [J]. BLOOD, 1999, 93 (04) : 1253 - 1263